Terzidis et al.
JOCArticle
1e, and this amount of energy seems to be enough for the
spontaneous hydrogen shift. The action of water on intermedia-
tes 12 during the workup procedure leads to formation of
products 5, most probably by formic acid abstraction, which
are estimated to have an energy profit for the unsubstituted
chromone of 33.89 kcal/mol and for the chloro-substituted
chromone of 34.65 kcal/mol. This amount of energy justifies
the spontaneous conversion of 12 to the isolated products 5,
in accordance to experimental results.
Optimized geometries (in Cartesian coordinates) for all
zwitterions 8a-8d, transition structures 4a-4n and 5a-5n,
intermediates 9a-9n, 11a-11n, 12a, and 12e, and products
5a, 5e are provided in Supporting Information.
formation of cyclopentachromenedicarboxylates 5, the iso-
lation of some natural cyclopentanobenzopyran-4-ones
(coniochaetones, wrightiadione, coniothyrione), which have
been ascribed antifungal and other medicinal properties24
and syntheses of which involve multistep processes,25 have
been reported. In addition, although the synthesis of some
cyclopentenobenzopyranones is known,26 no reference has
been made of a cyclopentadiene ring fused to a chromone
moiety. Finally, the formation of 6 and eventually 7 repre-
sent the first examples of a seven-membered ring formed by
an attack of a 1:2 zwitterionic intermediate to a CdC double
bond.
Experimental Section
Conclusions
General Procedure. Reaction of 3-Formylchromones (1) with
Isocyanides (2) and Acetylenedicarboxylates (3) in 20 mL of Solvent.
To a stirred thermostated at 40 °C solution of 3-formylchromone
(1.0 mmol) and acetylenedicarboxylate (1.2 mmol) in benzene
(20 mL) was added isocyanide (1.2 mmol) via a syringe, and the
reaction mixture was stirred at 40 °C until chromone was con-
sumed completely (followed by TLC, approximately 12 h). On
completion of the reaction, the solvent was removed under reduced
pressure, and the residue was subjected to chromatography (silica
gel 60, Fluka) using petroleum ether-AcOEt 7:1 as eluent, slowly
increasing the polarity up to 4:1 to give in elution order compounds
4, and/or 6 and/or 5 (see Table 1).
The present work demonstrates the versatility of chro-
mones in bringing about one-pot synthetic procedures, the
outcome of the reaction depending on both the nature of the
chromone substituents and the ester group in acetylenedi-
carboxylates. Thus, DMAD and electron-donating substit-
uents in the chromone moiety favor reaction with the alde-
hyde carbonyl, leading to chromenylfurandicarboxylates 4,
whereas electron-withdrawing substituents favor reaction
from the C2dC3 double bond, leading to cyclopentachro-
menedicarboxylates 5. By changing the dimethyl acetylene-
dicarboxylate to diethyl acetylenedicarboxylate, the cyclo-
pentachromenedicarboxylates 5 were preferentially formed
in all cases. Theoretical DFT calculations that have been
carried out for the first time on chromone moieties support
the experimental results.
In all studied reactions our initial goal, namely, the isola-
tion of products with an intact chromone moiety, was achie-
ved. In addition, to our knowledge, the isolation of chro-
menylfurandicarboxylates 4 constitutes one of very few
examples of a preferential attack to the formyl carbonyl over
the C-2 carbon of a nonactivated chromone leading to
formation of chromenyl heterocycles.20 To the contrary,
TMSCl-activated chromones have been found to be more
susceptible to nucleophilic attack to this carbon21 leading to
formation either of quinoline or of pyridobenzimidazole
derivatives. Highly functionalized 2-aminofuran derivatives
are isolated from the reaction of various carbonyl com-
pounds with isocyanides and acetylenedicarboxylates.22
Moreover, the few chromenylfurans reported in the litera-
ture show substantial biological activity.23 Concerning the
Data for Dimethyl 2-(tert-Butylamino)-5-(4-oxo-4H-chromen-
3-yl)furan-3,4-dicarboxylate (4a). Pale yellow crystals; mp
1
146-147 °C (CH2Cl2-petroleum ether); H NMR (300 MHz,
CDCl3) δ 1.47 (s, 9H, C(CH3)3), 3.77 (s, 3H, 3-OCH3), 3.92 (s,
3H, 4-OCH3), 6.92 (br s, 1H, NH), 7.37 (ddd, J = 8.0, J = 7.1,
J = 1.0 Hz, 60-H), 7.45 (ddd, J = 8.5, J = 1.0, J = 0.3 Hz, 1H,
80-H), 7.67 (ddd, J=8.5, J=7.1, J=1.75 Hz, 1H, 70-H), 8.23 (s,
1H, 20-H), 8.27 (ddd, J=8.0, J=1.75, J=0.3 Hz, 1H, 50-H); 13C
NMR(75 MHz, CDCl3) δ 29.9 (C(CH3)3), 51.2 (3-OCH3), 52.4
(4-OCH3), 52.8 (C(CH3)3), 88.3 (C-3), 115.8 (C-30), 117.6 (C-4),
118.1 (C-80), 123.8 (C-4a0), 125.5 (C-60), 126.5 (C-50), 133.6
(C-5), 133.8 (C-70), 152.9 (C-20), 155.8 (C-8a0), 161.7 (C-2),
165.11 (3-CdO), 165.14 (4-CdO), 173.7 (C-40). IR (KBr)
ν 3444, 1727, 1670 cm-1. LC-MS (ESI) m/z (%) 422 (Mþ þ
Na, 100), 400 (Mþ þ H, 50), 368 (15). Anal. Calcd for C21H21-
NO7 (399.39): C, 63.15; H, 5.30; N, 3.51. Found: C, 63.46; H,
5.40; N 3.42.
Data for Tetramethyl 10-(tert-Butylamino)-11-oxo-7,11-dihydro-
cyclohepta[b]chromene-6,7,8,9-tetracarboxylate (6a). Yellow crys-
tals; mp 185-188 °C (CH2Cl2-petroleum ether). 1H NMR (300
MHz, CDCl3) δ 1.49 (s, 9H, C(CH3)3), 3.56 (s, 3H, 7-OCH3), 3.71
(s, 3H, 9-OCH3), 3.84 (s, 3H, 6-OCH3 or 8-OCH3), 3.86 (s, 3H, 6-
OCH3 or 8-OCH3), 5.10 (s, 1H, 7-H), 7.21 (ddd, J=7.9, J=7.1,
J=1.0 Hz, 2-H), 7.25 (ddd, J=8.4, J=1.0, J=0.4 Hz, 1H, 4-H),
7.56 (ddd, J=8.4, J=7.1, J=1.7 Hz, 1H, 3-H), 8.04 (ddd, J=7.9,
J = 1.7, J = 0.4 Hz, 1H, 1-H), 13.20 (br s, 1H, NH); 13C NMR
(75 MHz, CDCl3) δ 29.5 (C(CH3)3), 44.6 (C-7), 52.0 (6-OCH3 or
8-OCH3), 52.7 (9-OCH3), 52.8 (7-OCH3), 53.0 (6-OCH3 or
8-OCH3), 57.8 (C(CH3)3), 100.7 (C-10a), 101.2 (C-6), 116.9
(C-4), 120.5 (C-11a), 121.1 (C-9), 123.2 (C-2), 125.8 (C-1), 134.5
(20) Raj, T.; Ishar, M. P. S.; Gupta, V.; Pannu, A. P. S.; Kanwal, P.;
Singh, G. Tetrahedron Lett. 2008, 49, 243.
(21) (a) Plaskon, A. S.; Ryabukhin, S. V.; Volochnyuk, D. M.;
Gavrilenko, K. S.; Shivanyuk, A. N.; Tolmachev, A. A. J. Org. Chem.
2008, 73, 6010. (b) Ryabukhin, S. V.; Plaskon, A. S.; Volochnyuk, D. M.;
Tolmachev, A. A. Synthesis 2007, 3155.
(22) (a) Nair, V.; Vinod, A. U. Chem. Commun. 2000, 1019. (b) Nair, V.;
Vinod, A. U.; Abhilash, N.; Menon, R. S.; Santhi, V.; Varma, R. L.; Viji, S.;
Mathew, S.; Srinivas, R. Tetrahedron 2003, 59, 10279. (c) Yadav, J. S.;
Reddy, B. V. Subba; Shubashree, S.; Sadashiv, K.; Naidu, Jaisree J. Synthesis
2004, 2376. (d) Azizian, J.; Mohammadizadeh, M. R.; Mohammadi, A. A.;
Karimi, A. R. Heteroat. Chem. 2005, 16, 259. (e) Adib, M.; Sayahi, M. H.;
Koloogani, S. A.; Mirzaei, P. Helv. Chim. Acta 2006, 89, 299. (f) Asghari, S.;
Qandalee, M. Acta Chim. Slov. 2007, 54, 638. (g) Hazeri, N.; Maghsoodlou,
M. T.; Habibi-Khorassani, S. M.; Marandi, G.; Khandan-Barani, K.;
Ziyaadini, M.; Aminkhani, A. Arkivoc 2007, i, 173.
(23) (a) Zhao, L.; Brinton, R. D. J. Med. Chem. 2005, 48, 3463.
(b) Edwards, B. S.; Bologa, C.; Young, S. M.; Balakin, K. V.; Prossnitz,
E. R.; Savchuck, N. P.; Sklar, L. A.; Oprea, T. I. Mol. Pharmacol. 2005, 68,
1301. (c) Sayed, H. M.; Mohamed, M. H.; Farag, S. F.; Mohamed, G. A.;
Proksch, P. Nat. Prod. Res. 2007, 21, 343.
(24) (a) Wang, H.-J.; Gloer, J. B.; Scott, J. A.; Malloch, D. Tetrahedron
Lett. 1995, 36, 5847. (b) Fujimoto, H.; Inagaki, M.; Satoh, Y.; Yoshida, E.;
Yamazaki, M. Chem. Pharm. Bull. 1996, 44, 1090. (c) Lin, L.-J.; Topcu, G.;
Lotter, H.; Ruangrungsi, N.; Wagner, H.; Pezzuto, J. M.; Cordell, G. A.
Phytochemistry 1992, 31, 4333. (d) Ondeyka, J. G.; Zink, D.; Basilio, A.;
Vicente, F.; Bills, G.; Diez, M. T.; Motyl, M.; Dezeny, G.; Byrne, K.; Singh,
S. B. J. Nat. Prod. 2007, 70, 668.
(25) (a) Mori, K.; Audran, G.; Monti, H. Synlett 1998, 259. (b) Thasana,
N.; Ruchirawat, S. Tetrahedron Lett. 2002, 43, 4515.
(26) Kumar, K.; Kapoor, R.; Kapur, A.; Ishar, M. P. S. Org. Lett. 2000, 2,
2023.
1954 J. Org. Chem. Vol. 75, No. 6, 2010